Company Description
Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally.
It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.
It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities.
The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment.
It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects.
The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors.
Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.
Country | United States |
Founded | 1936 |
IPO Date | Sep 20, 1995 |
Industry | Oil & Gas Equipment & Services |
Sector | Energy |
Employees | 3,600 |
CEO | Lawrence Bruno |
Contact Details
Address: 6316 Windfern Road Houston, Texas 77040 United States | |
Phone | 713 328 2673 |
Website | corelab.com |
Stock Details
Ticker Symbol | CLB |
Exchange | NYSE |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001000229 |
CUSIP Number | N22717107 |
ISIN Number | US21867A1051 |
SIC Code | 1389 |
Key Executives
Name | Position |
---|---|
Lawrence V. Bruno | Chairman of the Board, Chief Executive Officer, President and Chief Operating Officer |
Christopher Scott Hill | Senior Vice President and Chief Financial Officer |
Gwendolyn Y. Gresham M.B.A. | Senior Vice President of Corporate Development and Investor Relations |
Mark Damian Tattoli | Senior Vice President, Secretary and General Counsel |
Sow Hang Teo | Vice President, Treasurer and Chief Accounting Officer |
Leslie Linklater | Vice President People, Organization, and Culture |
Jacobus Schouten | Managing Director |
J. Donald Dumas Jr. | Senior Vice President of Production Enhancement and Business Development |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Jun 12, 2023 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
May 12, 2023 | 15F-12G | Filing |
May 2, 2023 | 25-NSE | Filing |
May 2, 2023 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
May 2, 2023 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
May 2, 2023 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
May 2, 2023 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
May 2, 2023 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
May 2, 2023 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
May 2, 2023 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |